Lakeside Holding Acquires Hupan Pharmaceutical (Hubei) to Enter Medical Logistics in China

November 11, 2024

Lakeside Holding Limited, through its wholly owned subsidiary Sichuan Hupan, entered into an equity transfer agreement to acquire Hupan Pharmaceutical (Hubei) Co., Ltd. for RMB 4.0 million (US$0.6 million). The acquisition is expected to add approximately US$7 million in annual revenue and expands Lakeside’s capabilities into China’s medical logistics sector.

Buyers
Lakeside Holding Limited, Sichuan Hupan Jincheng Enterprise Management Co., Ltd.
Targets
Hupan Pharmaceutical (Hubei) Co., Ltd.
Location
Hubei, China
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.